metabolic bone disease

Metabolic bone disease (MBD) in preterm infants is a condition marked by suboptimal bone mineralisation, arising primarily from the abrupt cessation of in utero mineral transfer during the critical ... GLP-1 drugs, such as Ozempic and Wegovy, may slightly increase the risk of osteoporosis, gout, and the rare metabolic bone disease osteomalacia, a recent study suggests. As these conditions are all ...

Understanding the Context

Business Wire: HSS Announces New Chief of Endocrinology Division and Metabolic Bone Service Benzinga on MSN: AstraZeneca scores pediatric win while adult trial falls short in rare bone disease AstraZeneca scores pediatric win while adult trial falls short in rare bone disease Metabolic diseases, including type 2 diabetes (T2D), obesity, and metabolic syndrome, are a growing threat to global public health. More than 537 million adults currently live with T2D, and this ... AstraZeneca Plc AZN released topline data from the Phase 3 program for efzimfotase alfa (ALXN1850) in the broad hypophosphatasia (HPP) patient population. HPP is a rare, inherited metabolic disorder ...